Fatigue Syndrome, Chronic Clinical Trial
Official title:
Effectiveness of Antrodia Cinnamomea Mycelia on Improving Immune Response in Subhealth People
NCT number | NCT05728918 |
Other study ID # | A-111-091 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | March 1, 2023 |
Est. completion date | April 30, 2024 |
This study aims to assess the effect of Antrodia cinnamomea mycelia on immune modulation in subhealth people.
Status | Recruiting |
Enrollment | 29 |
Est. completion date | April 30, 2024 |
Est. primary completion date | February 29, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 50 Years to 75 Years |
Eligibility | Inclusion Criteria: - Subjects are easy to feel fatigued - Subjects have poor sleep quality Exclusion Criteria: - Pregnant women or preparing for pregnancy. - Lactating women. - Women gave birth 6 months before the study. - Poor kindy and livers funcitons - Severe cardiovascular or other chronic diseases - Alcohol abuser - Using immune-associated supplements |
Country | Name | City | State |
---|---|---|---|
Taiwan | WanFang Hospital | Taipei |
Lead Sponsor | Collaborator |
---|---|
Greenyn Biotechnology Co., Ltd. |
Taiwan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Immune analysis | Changes in T cell markers of 29 participants will be analyzed between baseline and week 4. | Baseline up to 4 weeks | |
Primary | Immune analysis | Changes in B cell markers of 29 participants will be analyzed between baseline and week 4. | Baseline up to 4 weeks | |
Primary | Antibody analysis | Changes in IgA levels of 29 participants will be analyzed between baseline and week 4. | Baseline up to 4 weeks | |
Primary | Antibody analysis | Changes in IgD levels of 29 participants will be analyzed between baseline and week 4. | Baseline up to 4 weeks | |
Primary | Antibody analysis | Changes in IgG levels of 29 participants will be analyzed between baseline and week 4. | Baseline up to 4 weeks | |
Primary | Antibody analysis | Changes in IgE levels of 29 participants will be analyzed between baseline and week 4. | Baseline up to 4 weeks | |
Primary | Antibody analysis | Changes in IgM levels of 29 participants will be analyzed between baseline and week 4. | Baseline up to 4 weeks | |
Primary | Cytokine analysis | Changes in IL-1beta levels of 29 participants will be analyzed between baseline and week 4. | Baseline up to 4 weeks | |
Primary | Cytokine analysis | Changes in IL-4 levels of 29 participants will be analyzed between baseline and week 4. | Baseline up to 4 weeks | |
Primary | Cytokine analysis | Changes in IL-6 levels of 29 participants will be analyzed between baseline and week 4. | Baseline up to 4 weeks | |
Primary | Cytokine analysis | Changes inFN-gamma levels of 29 participants will be analyzed between baseline and week 4. | Baseline up to 4 weeks | |
Primary | Cytokine analysis | Changes in TNF-alpha levels of 29 participants will be analyzed between baseline and week 4. | Baseline up to 4 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05899595 -
Effects of a Personalized Physical Training to Reduce Fatigue
|
N/A | |
Not yet recruiting |
NCT01154647 -
Pain Inhibition in Patients With Rheumatoid Arthritis and Central Sensitivity Syndromes
|
N/A | |
Completed |
NCT00375973 -
Double Blind Trial of Duloxetine in Chronic Fatigue Syndrome
|
Phase 2/Phase 3 | |
Completed |
NCT02499302 -
Mental Training for CFS Following EBV Infection in Adolescents
|
N/A | |
Completed |
NCT02156128 -
Subjective Memory Complaints, Objective Memory Performance and Cognitive Training
|
N/A | |
Not yet recruiting |
NCT06386133 -
Chronic Fatigue in Multiple Sclerosis: MS Copilot Boost Solution Compared to Standard Care
|
N/A | |
Not yet recruiting |
NCT05116657 -
Obstructive Sleep Apnoea Post Covid 19: Role of the Upper Airway Microbiome
|
||
Completed |
NCT00788918 -
Study of Cerebral Function in Patients With Chronic Hepatitis C Infection (HCV/CNS)
|
N/A | |
Completed |
NCT04435002 -
The Effect of Acupressure on Fatigue in Individuals With Chronic Fatigue Syndrome
|
N/A | |
Recruiting |
NCT05778006 -
Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis (ME/CFS) Registry and Biobank, COVID-19, SARS-CoV-2
|
||
Recruiting |
NCT06253026 -
Fatigue in Air Search and Rescue Missions
|
||
Completed |
NCT00001415 -
Glucocorticoid Effects on Cellular Cytokine Release
|
N/A | |
Completed |
NCT04797871 -
Resistance Training and Clinical Status in Patients With Post Discharge Symptoms After Covid-19
|
N/A | |
Recruiting |
NCT04049331 -
Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone
|
Phase 2 | |
Completed |
NCT02335437 -
Chronic Fatigue Following Acute Epstein-Barr Virus Infection in Adolescents
|
N/A | |
Completed |
NCT04833673 -
The Effects of Relaxation Techniques on Pain, Fatigue and Kinesiophobia in Multiple Sclerosis Patients: A Three Arms Randomized Trial
|
N/A | |
Recruiting |
NCT04947488 -
Evaluation of the Effects of Treatment With Bioarginin C in Adult Subjects Belonging to the Post-Covid Day Hospital
|
N/A | |
Recruiting |
NCT05840237 -
REGAIN: RCT of Oxaloacetate for Fatigue in Long COVID
|
N/A | |
Active, not recruiting |
NCT04104750 -
The Assessment of Fatigue and Quality of Life in Patients With Bone Tumor,
|
||
Recruiting |
NCT03773003 -
Research for Pathophysiology of Cancer Related Fatigue (CRF) and Chronic Fatigue (CFS/ME)
|
N/A |